We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HI
1226
DELISTED
Hillenbrand
HI
| $1.55M | ﹤0.01% |
37,931
+26
| +0.1% | +$1.09K |
|
|
PGRE
1227
DELISTED
Paramount Group
PGRE
| $1.55M | ﹤0.01% |
217,997
+88,413
| +68% | +$800K |
|
|
BCPC
1228
Balchem Corp
BCPC
$5.71B
| $1.55M | ﹤0.01% |
11,941
-673
| -5% | -$84.2K |
|
|
BFS
1229
Saul Centers
BFS
$853M
| $1.55M | ﹤0.01% |
32,834
-993
| -3% | -$49K |
|
1230
Cognex
CGNX
$10.6B
| $1.54M | ﹤0.01% |
36,147
-124,569
| -78% | -$6.98M |
|
1231
Tilly's
TLYS
$127M
| $1.54M | ﹤0.01% |
218,868
+46,898
| +27% | +$391K |
|
1232
Oxford Industries
OXM
$542M
| $1.53M | ﹤0.01% |
17,302
-20,156
| -54% | -$1.81M |
|
1233
Kimco Realty
KIM
$16.1B
| $1.53M | ﹤0.01% |
77,672
-54,869
| -41% | -$1.26M |
|
|
AIMC
1234
DELISTED
Altra Industrial Motion Corp
AIMC
| $1.53M | ﹤0.01% |
43,494
-21,621
| -33% | -$804K |
|
1235
Boston Properties
BXP
$10.8B
| $1.53M | ﹤0.01% |
17,398
+2,268
| +15% | +$251K |
|
1236
Ligand Pharmaceuticals
LGND
$5.76B
| $1.53M | ﹤0.01% |
28,234
+15,969
| +130% | +$906K |
|
|
VTLE
1237
DELISTED
Vital Energy
VTLE
| $1.53M | ﹤0.01% |
22,143
+11,505
| +108% | +$923K |
|
1238
Terreno Realty
TRNO
$7.44B
| $1.52M | ﹤0.01% |
27,339
-4,798
| -15% | -$315K |
|
|
BVH
1239
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.51M | ﹤0.01% |
60,643
+28,069
| +86% | +$742K |
|
1240
Kosmos Energy
KOS
$1.52B
| $1.51M | ﹤0.01% |
243,569
+6,192
| +3% | +$44.7K |
|
1241
Cytokinetics
CYTK
$10.6B
| $1.5M | ﹤0.01% |
38,175
+1,267
| +3% | +$51K |
|
1242
Asbury Automotive
ABG
$3.73B
| $1.5M | ﹤0.01% |
8,854
-3,563
| -29% | -$617K |
|
1243
NRC Health Common Stock
NRC
$473M
| $1.5M | ﹤0.01% |
39,148
+5,054
| +15% | +$183K |
|
1244
NMI Holdings
NMIH
$3.34B
| $1.5M | ﹤0.01% |
89,776
+52,515
| +141% | +$954K |
|
|
CHUY
1245
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.5M | ﹤0.01% |
75,063
+48,335
| +181% | +$1.11M |
|
1246
Apple Hospitality REIT
APLE
$3.68B
| $1.49M | ﹤0.01% |
103,817
-6,299
| -6% | -$104K |
|
1247
Rayonier Advanced Materials
RYAM
$590M
| $1.49M | ﹤0.01% |
568,958
+435,095
| +325% | +$1.95M |
|
1248
Petrobras
PBR
$116B
| $1.49M | ﹤0.01% |
127,565
-12,962
| -9% | -$179K |
|
|
FITB
1249
Fifth Third Bancorp
FITB
$52.2B
| $1.49M | ﹤0.01% |
45,605
-96,602
| -68% | -$3.63M |
|
1250
Horace Mann Educators
HMN
$2.12B
| $1.49M | ﹤0.01% |
38,768
+4,039
| +12% | +$157K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.